Navigation Links
Benvenue Medical Closes $35.5 Million Series C Financing

SANTA CLARA, Calif., April 18, 2011 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced the completion of a $35.5 million Series C round of financing.  The proceeds will be used to complete KAST (Kiva® System as a Vertebral Augmentation Treatment – A Safety and Effectiveness Trial) and execute on the company's commercialization strategy.  Benvenue Medical is entering a $9 billion global spinal device market with three breakthrough minimally invasive products to treat vertebral compression fractures (VCFs) and degenerative disc disease (DDD).


The round was co-led by new investors Domain Associates and Technology Partners, with continued support from current investors Versant Ventures and DeNovo Ventures.  Nimesh Shah, principal at Domain Associates, and Roger Quy, general partner of Technology Partners, will join the Benvenue Medical Board of Directors.  

The funds will be used to complete enrollment and patient follow-up in Benvenue Medical's KAST trial, the largest randomized study versus balloon kyphoplasty to date, and begin multiple spine product commercialization initiatives in the U.S. and Europe. KAST is being conducted in support of 510(k) market clearance from the U.S. Food and Drug Administration (FDA) and is evaluating the Kiva VCF Treatment System versus balloon kyphoplasty in vertebral compression fractures. The Kiva VCF Treatment System has now been used to treat over 450 vertebral compression fractures globally.  The National Osteoporosis Foundation estimates that there are 700,000 osteoporosis-related vertebral compression fractures annually in the U.S.

"We welcome Domain Associates and Technology Partners as new investors and specifically Nimesh and Roger to our board.  We're also gratified by the continued support of Versant Ventures and DeNovo Ventures, who have been with us since the beginning.  Our investors share the vision of Benvenue Medical becoming a leading company with product platforms in multiple markets in spine repair," said Robert Weigle, CEO of Benvenue Medical.  "This significant financing is an important milestone for our continued momentum."

"With the landmark KAST Clinical Trial enrolling well, along with the go-to-market efforts already underway for Blazer and additional products, Benvenue Medical is well positioned to be a significant player in the global spine market.  We're very enthusiastic about being involved," said Nimesh Shah.

"We're impressed with Benvenue Medical's growth potential in both the VCF and fusion markets and we look forward to working with the company as it evolves into a commercially-focused organization," said Roger Quy.

"We at Versant Ventures are enthused by Benvenue's momentum on multiple fronts and are thrilled to have the caliber of investors of Domain Associates and Technology Partners join the team," said Beckie Robertson, managing director at Versant Ventures.

About Benvenue Medical, Inc.

Founded in 2004, Benvenue Medical, Inc. is advancing spine repair through the development of proprietary, minimally invasive surgical and interventional solutions. The company is privately held and funded by Versant Ventures, DeNovo Ventures, Domain Associates and Technology Partners.  Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined $1.6 billion revenues globally. For more information, visit

Betsy Merryman
Merryman Communications


SOURCE Benvenue Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OnPoint Medical Diagnostics, Inc. and Vertical Health Solutions, Inc. Complete Reverse Merger
2. FDA Approves New Medical Device for Form of Brain Cancer
3. Millstone Medical Outsourcing Expands Sales, Marketing Capacity, Hires Two Professionals
4. New Brachytherapy Applicator for Endometrial Cancer Patients Introduced at ABS 2011 by Varian Medical Systems
5. CVS Caremark to Offer Medical Benefit Drug Management Services to Clients
6. Palomar Medical Technologies to Host First Quarter 2011 Financial Results Conference Call and Webcast on April 28, 2011
7. Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China
8. Winner Medical to Attend 65th CMEF Spring11 Exhibition in Shenzhen
9. Solta Medical Announces First Quarter 2011 Results Release and Conference Call
10. Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations
11. BD and Waste Management Launch Initiative to Recycle Medical Sharps
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... -- Research and Markets ( ) has announced ... by Type (Dressings, Therapy Devices, Active Wound Care), Application ... and Geography - Global Forecast to 2020" report ... --> The purpose of this report is ... global advanced wound care market. It involves deep dive ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Italian therapeutic drug monitoring ...
Breaking Medicine Technology:
(Date:11/29/2015)... (PRWEB) , ... November 29, 2015 , ... Effective immediately, ... In addition starting on Black Friday Target is offering a “Buy One Scrub ... This is a rare opportunity to purchase IguanaMed at a discounted price. ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Trying to ... has created the COUCH BUDDY. "I conceived of this design due to personal experience ... for couch users. It promotes relaxation and convenience, as well as increases support. It ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of “Supporting ... Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately 250,000 ... through a vast social media strategy and across a network of top news ...
Breaking Medicine News(10 mins):